DETERMINATION OF VON WILLEBRAND FACTOR ACTIVITY AS METHOD FOR LABORATORY DIAGNOSIS OF SEVERITY OF SARS-COV-2 INFECTION Russian patent published in 2021 - IPC G01N33/50 

FIELD: medicine.

SUBSTANCE: invention relates to medicine and is connected with the method of laboratory diagnosis of the severity of the SARS-CoV-2 infection. The level of von Willebrand factor (VWF) in the blood serum of a patient with a laboratory-confirmed diagnosis of SARS-CoV-2 is additionally determined. If the level of VWF increases with regard to the upper normal level by 1.3 -1.5 times, mild infection is diagnosed. If the level of VWF increases with regard to the upper normal level by 1.51-2.5 times, the average severity of the infection is diagnosed. If the level of VWF increases with regard to the upper normal level by more than 2.51 times, severe infection is diagnosed.

EFFECT: invention provides the diagnosis of the severity of the SARS-CoV-2 infection, the distribution of patients into groups, followed by differentiated treatment.

1 cl, 3 ex